Impact Of ICTS' Decision, Kaspersky Stops Sales Of Software In The US

JAKARTA - Following the final decision of the United States Department of Commerce, Kaspersky announced that it had terminated its contract for sale of anti-virus software and cybersecurity products in the United States before July 20, 2024.

Starting September 30, 2024, Kaspersky will be banned from providing anti-virus signature updates and database updates to US consumers and businesses. Until then, the company will continue to fulfill its obligations based on all existing contracts.

This discontinuation was due to last June, Joe Biden's administration announced its plans to ban the sale of Kaspersky Lab antiviral devices in the US because they are considered to pose a critical risk to national security.

Then, responding to the news, Kaspersky has proposed a comprehensive assessment framework that provides solution verification, database updates, threat detection rules by independent and trusted reviewers.

Kaspersky is fully committed to transparency and provides high-quality protection against all kinds of threats.

The company also argues that the US decision is only based on a geopolitical climate and not on an evaluation of the integrity of the company's solutions so that users and companies there do not get the best protection in their class.

Nevertheless, Kaspersky continues to realize its mission to build a safer world, and continues to support its customers and partners around the world in providing leading cybersecurity solutions.

The company remains dedicated to delivering the best cybersecurity technology, which is recognized for its advantages through various independent awards and third-party audits.

Starting on July 20, 2024 yesterday, Kaspersky will also gradually reduce operations and eliminate US-based positions.